论文部分内容阅读
目的探讨红霉素在多种感染中的应用,同时对其与细菌细胞被膜之间的关系和临床疗效分析。方法将我院100例感染患者在临床应用红霉素抗菌治疗后,对其临床转归情况进行分析总结。结果我院100例不同病菌感染患者,口服红霉素肠溶片39例,静滴乳糖酸红霉素61例。不同给药途径应用红霉素后:显效58例占58%,有效35例占35%,无效7例占7%。结论霉素为抑菌剂,但在高浓度时对某些细菌也具杀菌作用,可透过细菌细胞膜抑制细菌蛋白质合成。
Objective To explore the application of erythromycin in a variety of infections and to analyze the relationship between erythromycin and bacterial cell envelope and clinical efficacy. Methods 100 cases of infected patients in our hospital after clinical application of erythromycin antibiotic treatment, the clinical outcome of the situation were analyzed and summarized. Results In our hospital, 100 patients with different pathogenic bacteria were infected with oral erythromycin enteric-coated tablets in 39 cases and intravenous infusion of erythromycin lactate in 61 cases. After different routes of administration of erythromycin: 58 cases markedly 58%, 35 cases effective 35%, 7 cases 7% ineffective. Conclusion As a bacteriostatic agent, butomycin is also bactericidal to certain bacteria at high concentration, which can inhibit the bacterial protein synthesis through the bacterial cell membrane.